A
ASTRIA THERAPEUTICS INC
NASDAQ: ATXS (Astria Therapeutics, Inc.)
最近更新时间: 4小时之前7.37
-0.06 (-0.81%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Astria Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.8
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.75 |
|
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 0.49% |
| 机构持股比例 | 106.43% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Fcpm Iii Services B.V. | 30 Jun 2025 | 4,107,537 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 26.00 (JMP Securities, 252.78%) | 购买 |
| 中 | 21.00 (184.94%) | |
| 低 | 16.00 (HC Wainwright & Co., 117.10%) | 购买 |
| 平均值 | 21.00 (184.94%) | |
| 总计 | 2 购买 | |
| 平均价格@调整类型 | 6.87 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| HC Wainwright & Co. | 13 Aug 2025 | 16.00 (117.10%) | 购买 | 6.87 |
| JMP Securities | 13 Aug 2025 | 26.00 (252.78%) | 购买 | 6.87 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合